Last updated on February 2019

Clinical Study of S-649266 for the Treatment of Nosocomial Pneumonia Caused by Gram-negative Pathogens


Brief description of study

To compare all-cause mortality at Day 14 in participants receiving S-649266 with participants receiving the comparator, meropenem, in adults with hospital-acquired bacterial pneumonia (HABP), ventilator-associated bacterial pneumonia (VABP), or healthcare-associated bacterial pneumonia (HCABP) caused by Gram-negative pathogens.

Clinical Study Identifier: NCT03032380

Contact Investigators or Research Sites near you

Start Over

Shionogi Clinical Trials Administrator Clinical ...

Shionogi Research Site
St. Petersburg, Russian Federation
  Connect »

Shionogi Clinical Trials Administrator Clinical ...

Shionogi Research Site
Sait-Petersburg, Russian Federation
7.22miles
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.